Skip to main content
. 2017 Feb 21;8(17):28595–28613. doi: 10.18632/oncotarget.15563

Figure 15. Enhancement of ValloVax activity by checkpoint inhibition.

Figure 15

Mice were implanted with LLC tumors, which were allowed to establish prior to immunization with ValloVax together with anti-CTLA4 A. or Anti-PD1 B. Tumor regression was assessed and each number indicates 12 animals per group. (*Animals were euthanized because of excessive tumor growth. ** p < 0.01 as compared to control, # p < .05 as compared to control).